Avid Bioservices Inc (CDMO)

[cjgaddy]

PPHM's Jeff Hutchins(VP/PreClinRes) speaking 3-16-16 at Immune Checkpoint Inhibitors Conf. (Boston).

Mar15-17 2016: Immune Checkpoint Inhibitors Conf., Boston
http://immune-checkpoint.com (Peregrine is 1 of 8 Corp. Sponsors)
3-16-16: Clinical Stream: “Enhance Combination Strategies to Maximize Efficacy”
11am: Patrick Ott, DANA-FARBER, “Critically Evaluate Mult. CI's in Combination”
11:30am: David Kaufman, MERCK, “Next-Gen.Biomarkers for the Era of Combo Cancer Immunotherapy”
12pm: Jon Wigginton, MACROGENICS, “Releasing the Brake: Enhancing Immunotherapy Through Rational Combos w/CI's”
-------
2pm: Jeff Hutchins (PEREGRINE/VP-PreClinRes), “Enhancing the Power of Checkpoint Inhibition by Simultaneously Blocking Upstream & Downstream Targets: The Role of Phosphatidylserine (PS), a Novel, Global Immune Checkpoint”
* Inhibiting PS using Bavituximab, a novel PS-signaling pathway inhibitor, blocks the immunosuppressive signal within the tumor microenvironment
* Assessing impact of immune stimulation through Fc?-receptor interaction on immune modulating cells
* Effects on multiple other immune effector cells will be presented
-------
2:30pm: Dirk Brockstedt, ADURO BIOTECH, “Discovery & Validation of the Next Generation of ICI's”